Prévisions du marché du traitement des troubles de l\'hyperpigmentation en Europe jusqu\'en 2030 - Analyse régionale - par type de traitement (cosméceutique, photothérapie ou laser, microdermabrasion, peelings chimiques, cryothérapie et autres), affection (mélasma, lentigines solaires, hyperpigmentation post-inflammatoire et autres) et utilisateur final (hôpitaux, centres de dermatologie et autres)
L\'augmentation du nombre de programmes de sensibilisation aux troubles de l\'hyperpigmentation stimule le marché européen du traitement des troubles de l\'hyperpigmentation
Les campagnes de sensibilisation à l\'hyperpigmentation cutanée induite par les UV sont essentielles pour éduquer le grand public sur la prévention, le dépistage, le diagnostic et le traitement de ces affections ; elles discutent également de l\'importance d\'utiliser des produits de protection solaire de bonne qualité pour gérer ces troubles.
Le 25 mai 2022, Bella Aurora a célébré la Journée internationale de la pigmentation de la peau. Avec plus de 130 ans d\'expérience dans la recherche sur la pigmentation de la peau, Bella Aurora a lancé une campagne internationale de sensibilisation pour célébrer la journée avec le soutien de dermatologues, de pharmaciens et de leaders d\'opinion renommés en Espagne et en Italie. En juin 2021, Dermalogica Clear a lancé une campagne pour encourager l\'acceptation de la peau et éduquer le public sur l\'hyperpigmentation post-inflammatoire, l\'acné, les éruptions cutanées, etc.
La sensibilisation accrue au mélasma et à d\'autres troubles d\'hyperpigmentation a entraîné une augmentation de la demande de produits et de procédures de traitement innovants et efficaces. De plus, elle a apporté un changement significatif et positif dans la façon dont la société comprend et gère l\'hyperpigmentation. Ainsi, le nombre croissant de programmes de sensibilisation soutient la croissance du marché du traitement des troubles de l\'hyperpigmentation.
Aperçu du marché européen du traitement des troubles de l\'hyperpigmentation
Le marché du traitement des troubles de l\'hyperpigmentation en Europe est segmenté en Allemagne, Royaume-Uni, France, Italie, Espagne et reste de l\'Europe. En 2023, l\'Allemagne détenait la plus grande part de marché européenne du traitement des troubles de l\'hyperpigmentation. Des facteurs tels que la sensibilisation croissante et l\'importance accordée aux soins de la peau et à la santé dermatologique au sein de la population stimulent la croissance du marché. Les Allemands sont de plus en plus proactifs dans la recherche de solutions de soins de la peau avancées pour traiter les troubles de l\'hyperpigmentation tels que le mélasma, les taches de vieillesse et l\'hyperpigmentation post-inflammatoire, ce qui stimule la demande de traitements innovants sur le marché. De plus, l\'augmentation du vieillissement de la population en Allemagne a entraîné de nombreux problèmes de peau liés à l\'âge, notamment l\'hyperpigmentation, incitant les individus à rechercher des traitements spécialisés pour conserver une peau éclatante. Selon l\'Office fédéral allemand des statistiques (Statistisches Bundesamt), le nombre de personnes âgées de 67 ans et plus passerait de 4 millions à au moins 20 millions d\'ici le milieu des années 2030. Une culture qui valorise les soins de la peau et les solutions anti-âge, associée au vieillissement de la population et à une prévalence élevée des maladies de la peau, contribue à la demande de traitements contre les troubles de l\'hyperpigmentation en Allemagne. Français En outre, l\'attention et les préoccupations croissantes concernant l\'apparence continuent d\'être un facteur clé dans l\'augmentation de la demande de diverses procédures cosmétiques, contribuant à une forte croissance du marché. De plus, la présence d\'infrastructures médicales avancées, de dermatologues qualifiés et de cliniques cosmétiques réputées en Allemagne contribue à l\'accessibilité d\'une large gamme de traitements et de procédures d\'hyperpigmentation, attirant les patients nationaux et internationaux à la recherche de services de soins de la peau de qualité.
Chiffre d\'affaires et prévisions du marché européen du traitement des troubles de l\'hyperpigmentation jusqu\'en 2030 (en millions de dollars américains)
Segmentation du marché européen du traitement des troubles de l\'hyperpigmentation
Le marché européen du traitement des troubles de l\'hyperpigmentation est classé en type de traitement, condition, utilisateur final et pays.
En fonction du type de traitement, le marché européen du traitement des troubles de l\'hyperpigmentation est segmenté en cosméceutique, thérapie par la lumière ou le laser, microdermabrasion, peelings chimiques, cryothérapie et autres. Français Le segment cosméceutique détenait la plus grande part de marché en 2022.
Sur la base des conditions, le marché européen du traitement des troubles de l\'hyperpigmentation est segmenté en mélasma, lentigines solaires, hyperpigmentation post-inflammatoire et autres. Le segment du mélasma détenait la plus grande part de marché en 2022.
Sur la base de l\'utilisateur final, le marché européen du traitement des troubles de l\'hyperpigmentation est segmenté en hôpitaux, centres de dermatologie et autres. Le segment des hôpitaux détenait la plus grande part de marché en 2022.
Par pays, le marché européen du traitement des troubles de l\'hyperpigmentation est segmenté en Allemagne, Royaume-Uni, France, Italie, Espagne et reste de l\'Europe. L\'Allemagne a dominé le marché européen du traitement des troubles de l\'hyperpigmentation en 2022.
AbbVie Inc, Bayer AG, EpiPharm AG, Galderma SA, L\'OREAL SA, Lutronic Co Ltd, Obagi Cosmeceuticals LLC et Pierre Fabre SA sont quelques-unes des principales sociétés opérant sur le marché européen du traitement des troubles de l\'hyperpigmentation.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Hyperpigmentation Disorder Treatment Market - Key Market Dynamics
4.1 Europe Hyperpigmentation Disorder Treatment Market - Key Market Dynamics
4.2 Market Drivers
4.2.1 Rise in Prevalence of Melasma
4.2.2 Increasing Number of Hyperpigmentation Disorder Awareness Programs
4.3 Market Restraints
4.3.1 High Cost of Treatments
4.4 Market Opportunities
4.4.1 Strategic Initiatives by Market Players
4.5 Future Trends
4.5.1 Use of Ablative Lasers
4.5.2 Novel Products Based on PATH-3 Technology
4.6 Impact of Drivers and Restraints:
5. Hyperpigmentation Disorder Treatment Market - Europe Analysis
5.1 Europe Hyperpigmentation Disorder Treatment Market Revenue (US$ Million), 2020-2030
6. Europe Hyperpigmentation Disorder Treatment Market Analysis - by Treatment Type
6.1 Cosmeceutical
6.1.1 Overview
6.1.2 Cosmeceutical: Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
6.2 Light or Laser Therapy
6.2.1 Overview
6.2.2 Light or Laser Therapy: Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
6.3 Microdermabrasion
6.3.1 Overview
6.3.2 Microdermabrasion: Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Chemical Peels
6.4.1 Overview
6.4.2 Chemical Peels: Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Cryotherapy
6.5.1 Overview
6.5.2 Cryotherapy: Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Others
6.6.1 Overview
6.6.2 Others: Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7. Europe Hyperpigmentation Disorder Treatment Market Analysis - by Condition
7.1 Melasma
7.1.1 Overview
7.1.2 Melasma: Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.2 Solar Lentigines
7.2.1 Overview
7.2.2 Solar Lentigines: Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Post-inflammatory Hyperpigmentation
7.3.1 Overview
7.3.2 Post-inflammatory Hyperpigmentation: Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Others
7.4.1 Overview
7.4.2 Others: Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8. Europe Hyperpigmentation Disorder Treatment Market Analysis - by End User
8.1 Hospitals
8.1.1 Overview
8.1.2 Hospitals: Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.2 Dermatology Centers
8.2.1 Overview
8.2.2 Dermatology Centers: Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Others
8.3.1 Overview
8.3.2 Others: Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
9. Europe Hyperpigmentation Disorder Treatment Market - Country Analysis
9.1 Europe Hyperpigmentation Disorder Treatment Market
9.1.1 Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast Analysis - by Country
9.1.1.1 Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast Analysis - by Country
9.1.1.2 Germany
9.1.1.3 Germany: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
9.1.1.3.1 Germany: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
9.1.1.3.2 Germany: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
9.1.1.3.3 Germany: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
9.1.1.4 UK
9.1.1.5 UK: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
9.1.1.5.1 UK: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
9.1.1.5.2 UK: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
9.1.1.5.3 UK: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
9.1.1.6 France
9.1.1.7 France: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
9.1.1.7.1 France: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
9.1.1.7.2 France: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
9.1.1.7.3 France: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
9.1.1.8 Italy
9.1.1.9 Italy: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
9.1.1.9.1 Italy: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
9.1.1.9.2 Italy: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
9.1.1.9.3 Italy: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
9.1.1.10 Spain
9.1.1.11 Spain: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
9.1.1.11.1 Spain: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
9.1.1.11.2 Spain: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
9.1.1.11.3 Spain: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
9.1.1.12 Rest of Europe
9.1.1.13 Rest of Europe: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
9.1.1.13.1 Rest of Europe: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
9.1.1.13.2 Rest of Europe: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
9.1.1.13.3 Rest of Europe: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
10. Hyperpigmentation Disorder Treatment Market - Industry Landscape
10.1 Overview
10.2 Growth Strategies in Hyperpigmentation Disorder Treatment Market
10.3 Organic Growth Strategies
10.3.1 Overview
10.4 Inorganic Growth Strategies
10.4.1 Overview
11. Company Profiles
11.1 AbbVie Inc
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 EpiPharm AG
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Galderma SA
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Obagi Cosmeceuticals LLC
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Bayer AG
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Lutronic Co Ltd
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 L'OREAL S.A.
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Pierre Fabre SA
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary of Terms
List of Tables
Table 1. Europe Hyperpigmentation Disorder Treatment Market Segmentation
Table 2. Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Treatment Type
Table 3. Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Condition
Table 4. Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by End User
Table 5. Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Country
Table 6. Germany: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Treatment Type
Table 7. Germany: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Condition
Table 8. Germany: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by End User
Table 9. UK: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Treatment Type
Table 10. UK: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Condition
Table 11. UK: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by End User
Table 12. France: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Treatment Type
Table 13. France: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Condition
Table 14. France: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by End User
Table 15. Italy: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Treatment Type
Table 16. Italy: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Condition
Table 17. Italy: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by End User
Table 18. Spain: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Treatment Type
Table 19. Spain: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Condition
Table 20. Spain: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by End User
Table 21. Rest of Europe: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Treatment Type
Table 22. Rest of Europe: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Condition
Table 23. Rest of Europe: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by End User
Table 24. Recent Organic Growth Strategies in Hyperpigmentation Disorder Treatment Market
Table 25. Recent Inorganic Growth Strategies in the Hyperpigmentation Disorder Treatment Market
Table 26. Glossary of Terms, Hyperpigmentation Disorder Treatment Market
List of Figures
Figure 1. Europe Hyperpigmentation Disorder Treatment Market Segmentation, by Country
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. Europe Hyperpigmentation Disorder Treatment Market Revenue (US$ Million), 2020-2030
Figure 4. Europe Hyperpigmentation Disorder Treatment Market Share (%) - by Treatment Type (2022 and 2030)
Figure 5. Cosmeceutical: Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 6. Light or Laser Therapy: Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Microdermabrasion: Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Chemical Peels: Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Cryotherapy: Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Others: Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Europe Hyperpigmentation Disorder Treatment Market Share (%) - by Condition (2022 and 2030)
Figure 12. Melasma: Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Solar Lentigines: Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Post-inflammatory Hyperpigmentation: Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Others: Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Europe Hyperpigmentation Disorder Treatment Market Share (%) - by End User (2022 and 2030)
Figure 17. Hospitals: Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Dermatology Centers: Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Others: Europe Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Europe Hyperpigmentation Disorder Treatment Market, By Key Country - Revenue (2022) (US$ Million)
Figure 21. Europe Hyperpigmentation Disorder Treatment Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 22. Germany: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. UK: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. France: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Italy: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Spain: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Rest of Europe: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Growth Strategies in Hyperpigmentation Disorder Treatment Market
- AbbVie Inc
- Bayer AG
- EpiPharm AG
- Galderma SA
- L'OREAL S.A.
- Lutronic Co Ltd
- Obagi Cosmeceuticals LLC
- Pierre Fabre SA
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe hyperpigmentation disorder treatment market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Europe hyperpigmentation disorder treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Europe hyperpigmentation disorder treatment market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.